WASHINGTON, Nov. 4 (UPI) -- An antibiotic treatment for
gonorrhea was found by the Centers for Disease Control and
Prevention to be losing its effectiveness, although researchers
at the agency said while this is cause for concern, the drug is
not the only way to treat the sexually transmitted infection.
Gonorrhea is spread through unprotected sex and, if untreated,
can cause serious health complications. The STI can effectively
be treated with antibiotics, however at least one, cefixime,
appears to be losing its efficacy.
According to the CDC, the infection's resistance to cefixime
went down from 2011 to 2013, but the drug appeared to start
losing effectiveness in 2014. The drug is not the primary method
of treating gonorrhea; guidelines issued in 2012 recommend a
ceftriaxone-based combination therapy that remains effective.
"It is essential to continue monitoring antimicrobial
susceptibility and track patterns of resistance among the
antibiotics currently used to treat gonorrhea," Dr. Robert
Kirkcaldy, an epidemiologist at the CDC, told HealthDay. "Recent
increases in cefixime resistance show our work is far from over."
Researchers at the CDC looked at samples from 51,144 male
gonorrhea patients gathered at public clinics between 2006 and
2014. Of the samples, one-third were from the western part of
the United States and one-third from the South, and about a
quarter of them were drawn from gay or bisexual men.
The amount of patients given the combination therapy increased
from 9 percent in 2006 to 97 percent in 2014 as a result of a
change in treatment guidelines in 2012.
The researchers found that resistance to cefixime increased from
0.1 percent in 2006 to 1.4 percent in 2011, before dropping to
0.4 percent in 2013. However, resistance began to increase again
in 2014, rising to 0.8 percent, raising researchers' concerns.
"Trends of cefixime susceptibility have historically been a
precursor to trends in ceftriaxone," Kirkcaldy said. "So it's
important to continue monitoring cefixime to be able to
anticipate what might happen with other drugs in the future."
http://www.upi.com/Health_News/2015/11/04/CDC-Gonorrhea-becoming-
more-resistant-to-one-antibiotic/8441446667726/
Check out who the biggest spreaders are, black queers like Obama.
http://www.cdc.gov/msmhealth/images/msm-couple2.jpg
Sexually Transmitted Diseases (STDs) have been rising among gay
and bisexual men, with increases in syphilis being seen across
the country. In 2013, gay, bisexual, and other men who have sex
with men accounted for 75% of primary and secondary syphilis
cases in the United States. Gay, bisexual, and other men who
have sex with men often get other STDs, including chlamydia and
gonorrhea infections. HPV (Human papillomavirus), the most
common STD in the United States, is also a concern for gay,
bisexual, and other men who have sex with men. Some types of HPV
can cause genital and anal warts and some can lead to the
development of anal and oral cancers. Gay, bisexual, and other
men who have sex with men are 17 times more likely to get anal
cancer than heterosexual men. Men who are HIV-positive are even
more likely than those who do not have HIV to get anal cancer.
http://www.cdc.gov/msmhealth/std.htm
Rectal gonorrhoea in homosexual men: source of infection.
The objective of this retrospective study was to determine the
possible source of infection in homosexual men with rectal
gonorrhoea: the probable source of rectal gonorrhoea was
identified in 46/155 cases. Although the urethra was the site of
infection in 33 (72%) of these contacts, only pharyngeal
gonorrhoea was identified in 9 (20%) men. In 25/26 cases, there
was concordance in the auxo/serotypes of Neisseria gonorrhoeae
between contacts with urethral gonorrhoea and the index men with
rectal gonorrhoea. Eleven out of 12 pharyngeal isolates were of
the same auxo/serotype as the index cases. This study supports
the hypothesis that rectal gonorrhoea in homosexual men can be
acquired from the oropharynx. Because infection at this site is
an independent risk factor for acquisition of HIV, screening for
rectal and pharyngeal gonorrhoea should be offered to men who
have sex with men, even when there is no history of unprotected
receptive anal intercourse.
http://www.ncbi.nlm.nih.gov/pubmed/10824935
Syphilis and gonorrhea on the rise in the U.S. - especially
among gay men and young people
The CDC reports that syphilis cases rose 11.1 per cent between
2011 and 2012
The rise was only among men who have sex with men who account
for 75 per cent off all cases of primary and secondary syphilis
Reported cases of gonorrhea rose 4.1 per cent, mostly among
among young men and women aged 15 to 24
The CDC says there are likely to be much higher numbers of
unreported and undiagnosed STDs
Untreated STDs cause 24,000 women in America to become infertile
each year
STDs cost the U.S. $16 billion annually
http://www.dailymail.co.uk/news/article-2536846/Syphilis-
gonorrhea-rise-U-S-especially-gay-men-young-people.html